Could an Eli Lilly and Co. drug used to treat patients with rheumatoid arthritis work on those suffering from COVID-19?  We get a top Lilly executive’s take on the drug and why the company feels obligated to test it.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}